Anna Pierce

698 total citations
27 papers, 399 citations indexed

About

Anna Pierce is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Anna Pierce has authored 27 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Epidemiology and 5 papers in General Health Professions. Recurrent topics in Anna Pierce's work include HIV/AIDS Research and Interventions (8 papers), HIV, Drug Use, Sexual Risk (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Anna Pierce is often cited by papers focused on HIV/AIDS Research and Interventions (8 papers), HIV, Drug Use, Sexual Risk (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Anna Pierce collaborates with scholars based in Australia, United States and Germany. Anna Pierce's co-authors include Jennifer Hoy, John McAllister, Sharon A. Greene, Mark D. Sobsey, David Sweat, Jude Armishaw, Aron J. Hall, Peter McCluskey, Anthony J. Hall and Neil Howell and has published in prestigious journals such as Neurology, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Anna Pierce

22 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Pierce Australia 10 221 161 83 71 54 27 399
Maria Christine Thurnheer Switzerland 8 150 0.7× 142 0.9× 60 0.7× 66 0.9× 38 0.7× 16 304
Hongzhou Lu China 10 155 0.7× 127 0.8× 56 0.7× 38 0.5× 69 1.3× 24 278
Mariane Martins de Araújo Stefani Brazil 14 433 2.0× 170 1.1× 195 2.3× 15 0.2× 33 0.6× 34 480
Samuel George Hansdak India 10 92 0.4× 113 0.7× 64 0.8× 15 0.2× 31 0.6× 36 363
Christian Aquilina France 8 246 1.1× 63 0.4× 241 2.9× 195 2.7× 23 0.4× 10 399
Visva Pillay South Africa 12 353 1.6× 83 0.5× 294 3.5× 27 0.4× 46 0.9× 18 524
Saba M. Lambert United Kingdom 12 366 1.7× 169 1.0× 10 0.1× 49 0.7× 31 0.6× 30 440
CC Onyenekwe Nigeria 9 100 0.5× 99 0.6× 88 1.1× 66 0.9× 29 0.5× 70 402
Kathrin van Bremen Germany 7 92 0.4× 145 0.9× 76 0.9× 60 0.8× 33 0.6× 17 244
Hyppolite K. Tchidjou Italy 12 123 0.6× 103 0.6× 91 1.1× 39 0.5× 46 0.9× 32 349

Countries citing papers authored by Anna Pierce

Since Specialization
Citations

This map shows the geographic impact of Anna Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Pierce more than expected).

Fields of papers citing papers by Anna Pierce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Pierce. The network helps show where Anna Pierce may publish in the future.

Co-authorship network of co-authors of Anna Pierce

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Pierce. A scholar is included among the top collaborators of Anna Pierce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Pierce. Anna Pierce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pierce, Anna. (2024). Management of occupational exposure to blood and body fluids in primary care. Australian Prescriber. 47(4). 113–118.
2.
Mansfield, Carol, et al.. (2024). Patient Preferences for Myasthenia Gravis Treatments: A Discrete-choice Experiment (P4-11.013). Neurology. 102(7_supplement_1).
3.
Kosa, Katherine, Caroline Vass, Magaly Perez‐Nieves, et al.. (2024). Perspectives and Preferences of People with Type 2 Diabetes for the Attributes of Weekly Insulin. Diabetes Therapy. 15(11). 2367–2379. 1 indexed citations
4.
Vietri, Jeffrey, Liping Huang, Vincenza Snow, et al.. (2023). 1740. Healthcare Providers’ Preferences for Pediatric Pneumococcal Vaccination Recommendations in the United States. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
5.
Crouch, Simon, et al.. (2023). Mpox Management: A Holistic Local Response to a Global Threat. Journal of Public Health Management and Practice. 30(2). 204–207. 3 indexed citations
6.
Janssen, Ellen M., Ian Smith, Xiaoying Liu, et al.. (2023). Patient Preferences for Lung Cancer Interception Therapy. JAMA Network Open. 6(11). e2342681–e2342681. 3 indexed citations
7.
Ho, Kerrie-Anne, et al.. (2023). Eliciting Exploratory Patient Preference Data: A Case Study in a Rare Disease. Pharmaceutical Medicine. 38(1). 55–62. 2 indexed citations
8.
Gregory, Gareth P., Anna Pierce, Julian Druce, et al.. (2021). Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient. Infection Control and Hospital Epidemiology. 43(6). 820–822. 4 indexed citations
9.
Pierce, Anna. (2018). Theory of Planned Behavior Applied to High School Science Teachers Implementing Next Generation Science Standards. Scholarship & Creative Works - Digital UNC a service of University Libraries (University of Northern Colorado). 3 indexed citations
10.
McAllister, John, Janet M Towns, Anna McNulty, et al.. (2017). Dolutegravir with tenofovir disoproxil fumarate–emtricitabine as HIV postexposure prophylaxis in gay and bisexual men. AIDS. 31(9). 1291–1295. 16 indexed citations
11.
Foster, Rosalind, et al.. (2015). Single-Tablet Emtricitabine-Rilpivirine-Tenofovir as HIV Postexposure Prophylaxis in Men Who Have Sex With Men. Clinical Infectious Diseases. 61(8). 1336–1341. 32 indexed citations
12.
Pierce, Anna, et al.. (2013). Developing an evidence‐based guideline for the management of exposure to hepatitis B at a Victorian tertiary hospital. Australian and New Zealand Journal of Public Health. 37(5). 411–415. 2 indexed citations
13.
Leeansyah, Edwin, Paul Cameron, Ajantha Solomon, et al.. (2013). Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging. The Journal of Infectious Diseases. 207(7). 1157–1165. 105 indexed citations
14.
Bloch, Mark, Jennifer Hoy, Nicola Cunningham, et al.. (2012). Adherence to HIV Treatment Guidelines for Comorbid Disease Assessment and Initiation of Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(5). 478–488. 9 indexed citations
15.
Sweat, David, et al.. (2011). Norovirus outbreak associated with undercooked oysters and secondary household transmission. Epidemiology and Infection. 140(2). 276–282. 76 indexed citations
16.
Pierce, Anna, Keflemariam Yohannes, Rebecca Guy, et al.. (2011). HIV seroconversions among male non-occupational post-exposure prophylaxis service users: a data linkage study. Sexual Health. 8(2). 179–179. 14 indexed citations
17.
Hayden, Carol, et al.. (2010). Comprehensive Area Assessment: An evaluation of year 1. ORCA Online Research @Cardiff (Cardiff University).
18.
McAllister, John, et al.. (2009). Cost‐effectiveness of HIV nonoccupational post‐exposure prophylaxis in Australia. HIV Medicine. 10(4). 199–208. 14 indexed citations
19.
Mackey, David A., John H. Fingert, Peter McCluskey, et al.. (2003). Leber's hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus. Eye. 17(3). 312–317. 55 indexed citations
20.
Pierce, Anna & Jennifer Hoy. (2001). Is the recommendation for pneumococcal vaccination of HIV patients evidence based?. Journal of Clinical Virology. 22(3). 255–261. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Christine Thurnheer Breakdown of academic impact, for papers by Hongzhou Lu Breakdown of academic impact, for papers by Mariane Martins de Araújo Stefani Breakdown of academic impact, for papers by Samuel George Hansdak Breakdown of academic impact, for papers by Christian Aquilina Breakdown of academic impact, for papers by Visva Pillay Breakdown of academic impact, for papers by Saba M. Lambert Breakdown of academic impact, for papers by CC Onyenekwe Breakdown of academic impact, for papers by Kathrin van Bremen Breakdown of academic impact, for papers by Hyppolite K. Tchidjou
Rankless by CCL
2026